Cargando…

The Interplay between Drivers of Erythropoiesis and Iron Homeostasis in Rare Hereditary Anemias: Tipping the Balance

Rare hereditary anemias (RHA) represent a group of disorders characterized by either impaired production of erythrocytes or decreased survival (i.e., hemolysis). In RHA, the regulation of iron metabolism and erythropoiesis is often disturbed, leading to iron overload or worsening of chronic anemia d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grootendorst, Simon, de Wilde, Jonathan, van Dooijeweert, Birgit, van Vuren, Annelies, van Solinge, Wouter, Schutgens, Roger, van Wijk, Richard, Bartels, Marije
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927117/ https://www.ncbi.nlm.nih.gov/pubmed/33672223 http://dx.doi.org/10.3390/ijms22042204

Ejemplares similares

A Comprehensive Analysis of the Erythropoietin-erythroferrone-hepcidin Pathway in Hereditary Hemolytic Anemias
por: van Vuren, Annelies J., et al.
Publicado: (2021)

GATA-1 Defects in Diamond–Blackfan Anemia: Phenotypic Characterization Points to a Specific Subset of Disease
por: van Dooijeweert, Birgit, et al.
Publicado: (2022)

Proton pump inhibition for secondary hemochromatosis in hereditary anemia: a phase III placebo‐controlled randomized cross‐over clinical trial
por: van Vuren, Annelies, et al.
Publicado: (2022)

Transfusion burden in early childhood plays an important role in iron overload in Diamond‐Blackfan anaemia
por: de Wilde, Jonathan R. A., et al.
Publicado: (2022)

Red blood cell vesiculation in hereditary hemolytic anemia
por: Alaarg, Amr, et al.
Publicado: (2013)

Metabolic Fingerprint in Hereditary Spherocytosis Correlates With Red Blood Cell Characteristics and Clinical Severity
por: van Dooijeweert, Birgit, et al.
Publicado: (2021)

The Complexity of Genotype-Phenotype Correlations in Hereditary Spherocytosis: A Cohort of 95 Patients: Genotype-Phenotype Correlation in Hereditary Spherocytosis
por: van Vuren, Annelies, et al.
Publicado: (2019)

A Proposed Concept for Defective Mitophagy Leading to Late Stage Ineffective Erythropoiesis in Pyruvate Kinase Deficiency
por: van Vuren, Annelies Johanna, et al.
Publicado: (2021)

P1566: PROTON PUMP INHIBITION FOR SECONDARY HEMOCHROMATOSIS IN HEREDITARY ANEMIA, A PHASE III PLACEBO-CONTROLLED RANDOMIZED CROSS-OVER CLINICAL TRIAL
por: Van Vuren, A., et al.
Publicado: (2022)

A Unique Monocyte Transcriptome Discriminates Sickle Cell Disease From Other Hereditary Hemolytic Anemias and Shows the Particular Importance of Lipid and Interferon Signaling
por: van Vuren, Annelies J., et al.
Publicado: (2021)

Dried blood spot metabolomics reveals a metabolic fingerprint with diagnostic potential for Diamond Blackfan Anaemia
por: van Dooijeweert, Birgit, et al.
Publicado: (2021)

Untargeted metabolic profiling in dried blood spots identifies disease fingerprint for pyruvate kinase deficiency
por: van Dooijeweert, Birgit, et al.
Publicado: (2020)

Tips for erythropoiesis-stimulating agent treatment of renal anemia
por: Tomosugi, Naohisa, et al.
Publicado: (2019)

Liver Iron Retention Estimated from Utilization of Oral and Intravenous Radioiron in Various Anemias and Hemochromatosis in Humans
por: van Vuren, Annelies J., et al.
Publicado: (2020)

P1424: ONE-YEAR FOLLOW-UP OF A PHASE 2 STUDY OF MITAPIVAT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR THE TREATMENT OF SICKLE CELL DISEASE
por: van Dijk, Myrthe, et al.
Publicado: (2023)

In-vitro and in-silico evidence for oxidative stress as drivers for RDW
por: Joosse, Huibert-Jan, et al.
Publicado: (2023)

Erythropoiesis and Malaria, a Multifaceted Interplay
por: Dumarchey, Aurélie, et al.
Publicado: (2022)

Iron overload in patients with rare hereditary hemolytic anemia: Evidence‐based suggestion on whom and how to screen
por: van Straaten, Stephanie, et al.
Publicado: (2018)

Zebrafish erythropoiesis and the utility of fish as models of anemia
por: Kulkeaw, Kasem, et al.
Publicado: (2012)

Interplay of Vitamin D, Erythropoiesis, and the Renin-Angiotensin System
por: Santoro, Domenico, et al.
Publicado: (2015)

Motivational Drivers of Temporal Dynamics in Postretirement Work
por: Hansson, Isabelle, et al.
Publicado: (2022)

PI-02: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE
por: M., VAN DIJK, et al.
Publicado: (2022)

Ektacytometry Analysis of Post-splenectomy Red Blood Cell Properties Identifies Cell Membrane Stability Test as a Novel Biomarker of Membrane Health in Hereditary Spherocytosis
por: Berrevoets, M. C., et al.
Publicado: (2021)

Chk1 Haploinsufficiency Results in Anemia and Defective Erythropoiesis
por: Boles, Nathan C., et al.
Publicado: (2010)

Treatment of renal anemia: Erythropoiesis stimulating agents and beyond
por: Biggar, Patrick, et al.
Publicado: (2017)

P1481: SYSTEMATICALLY REDUCED RED CELL PHOSPHATIDYLSERINE FLIPPASE ACTIVITY IS SUFFICIENT TO INDUCE HEREDITARY HEMOLYTIC ANEMIA
por: van Dijk, Myrthe, et al.
Publicado: (2023)

P717: AG946, A PYRUVATE KINASE (PK) ACTIVATOR IMPROVES PK PROPERTIES AND RED BLOOD CELL (RBC) METABOLISM UPON EX VIVO TREATMENT OF RBCS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES
por: de Wilde, Jonathan, et al.
Publicado: (2023)

The EPO-FGF23 Signaling Pathway in Erythroid Progenitor Cells: Opening a New Area of Research
por: van Vuren, Annelies J., et al.
Publicado: (2019)

Mechanical Stress Induces Ca(2+)-Dependent Signal Transduction in Erythroblasts and Modulates Erythropoiesis
por: Aglialoro, Francesca, et al.
Publicado: (2021)

A critical role for mTORC1 in erythropoiesis and anemia
por: Knight, Zachary A, et al.
Publicado: (2014)

Editorial: Pathophysiology of Rare Hemolytic Anemias
por: van Wijk, Richard, et al.
Publicado: (2020)

Squeezing for Life – Properties of Red Blood Cell Deformability
por: Huisjes, Rick, et al.
Publicado: (2018)

Density, heterogeneity and deformability of red cells as markers of clinical severity in hereditary spherocytosis
por: Huisjes, Rick, et al.
Publicado: (2020)

Anemia in Patients With Resistance to Thyroid Hormone α: A Role for Thyroid Hormone Receptor α in Human Erythropoiesis
por: van Gucht, Anja L. M., et al.
Publicado: (2017)

S277: IPSC DISEASE MODELS TO STUDY AND TREAT DIAMOND-BLACKFAN ANEMIA SYNDROME (DBAS)
por: Clark, Chantal, et al.
Publicado: (2023)

Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia
por: Pashos, Chris L., et al.
Publicado: (2011)

Defective erythropoiesis in bone marrow is a mechanism of anemia in children with cancer.
por: Kim, MunHee, et al.
Publicado: (2002)

Pro-Inflammatory Cytokine-Mediated Anemia: Regarding Molecular Mechanisms of Erythropoiesis
por: Morceau, F., et al.
Publicado: (2009)

Protective roles of erythropoiesis-stimulating proteins in chronic heart failure with anemia
por: ZHOU, SHUQIN, et al.
Publicado: (2014)

NFAT-mediated defects in erythropoiesis cause anemia in Il2(−/−) mice
por: Giampaolo, Sabrina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lq4ahv29oo8qm0ob2mja45o1f5